​

Cartesian Therapeutics Ownership | Who Owns Cartesian Therapeutics?

OverviewForecastRevenueFinancialsChart

Cartesian Therapeutics Ownership Summary

Cartesian Therapeutics is owned by 25.41% institutional investors, 77.58% insiders. Hall laurie j trustee is the largest institutional shareholder, holding 0% of RNAC shares. Fidelity Select Biotechnology is the top mutual fund, with 2.61% of its assets in Cartesian Therapeutics shares.

RNAC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCartesian Therapeutics25.41%77.58%-2.99%
SectorHealthcare Stocks 79.84%9.81%10.35%
IndustryBiotech Stocks 63.50%9.87%26.63%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Hall laurie j trustee---
Johnson financial group---
Truvestments capital---
Boothbay fund management---
Squarepoint ops---
Farther finance advisors---
Virtus etf advisers---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Hall laurie j trustee---
Johnson financial group---
Truvestments capital---
Boothbay fund management---
Squarepoint ops---
Farther finance advisors---
Virtus etf advisers---

Top Buyers

HolderShares% AssetsChange
Truvestments capital---10.00
Farther finance advisors---18.00
Hall laurie j trustee---1.76K
Virtus etf advisers---3.53K
Johnson financial group---4.62K

Top Sellers

HolderShares% AssetsChange
Boothbay fund management---14.49K
Squarepoint ops---10.65K
Johnson financial group---4.62K
Virtus etf advisers---3.53K
Hall laurie j trustee---1.76K

Sold Out

HolderChange
Truvestments capital-10.00
Farther finance advisors-18.00
Hall laurie j trustee-1.76K
Virtus etf advisers-3.53K
Johnson financial group-4.62K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025684.62%6,582,0911.37%25145.00%33-25.00%18125.00%
Dec 31, 2024666.45%6,666,026-2.94%421.92%4528.57%8-11.11%
Sep 30, 2024625.08%6,868,068109.92%499.52%35-37.50%9200.00%
Jun 30, 2024591375.00%3,271,748176274.56%2-561300.00%3-
Mar 31, 20244-1,855---4---

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Select Biotechnology675.95K2.61%-90.80K
Fidelity Growth Compy Commingled Pl S462.41K1.78%-
HBM Healthcare Investments AG Ord415.23K1.60%-
Fidelity Select Health Care368.99K1.42%-
Fidelity Growth Company Fund341.04K1.32%-
Vanguard Total Stock Mkt Idx Inv287.99K1.11%-
iShares Russell 2000 ETF251.32K0.97%42.00
Fidelity Advisor Health Care I230.25K0.89%-
Fidelity Advisor Biotechnology I167.95K0.66%167.95K
Vanguard Institutional Extnd Mkt Idx Tr133.78K0.52%-

Recent Insider Transactions

DateNameRoleActivityValue
Apr 09, 2025SPRINGER TIMOTHY A Buy$308.48
Apr 11, 2025SPRINGER TIMOTHY A Buy$69.07K
Apr 10, 2025SPRINGER TIMOTHY A Buy$6.65K
Apr 10, 2025SPRINGER TIMOTHY A Buy$83.12K
Apr 09, 2025SPRINGER TIMOTHY A Buy$69.21K

Insider Transactions Trends

DateBuySell
2025 Q210-
2025 Q1612
2024 Q42017
2024 Q32-
2024 Q2--

RNAC Ownership FAQ

Who Owns Cartesian Therapeutics?

Cartesian Therapeutics shareholders are primarily institutional investors at 25.41%, followed by 77.58% insiders and -2.99% retail investors. The average institutional ownership in Cartesian Therapeutics's industry, Biotech Stocks , is 63.50%, which Cartesian Therapeutics falls below.

Who owns the most shares of Cartesian Therapeutics?

Cartesian Therapeutics’s largest shareholders are Hall laurie j trustee (0 shares, 0%), Johnson financial group (0 shares, 0%), and Truvestments capital (0 shares, 0%). Together, they hold 0% of Cartesian Therapeutics’s total shares outstanding.

Does Blackrock own Cartesian Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cartesian Therapeutics.

Who is Cartesian Therapeutics’s biggest shareholder by percentage of total assets invested?

Hall laurie j trustee is Cartesian Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Cartesian Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Cartesian Therapeutics shares?

Fidelity Select Biotechnology is the top mutual fund holder of Cartesian Therapeutics shares, with 2.61% of its total shares outstanding invested in 675.95K Cartesian Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools